Simran Farms Limited reported a consolidated net profit of ₹508.77 lakh for the financial year ended March 31, 2026, compared to ₹589.61 lakh in the previous year. Total revenue for the year increased to ₹87719.02 lakh from ₹83624.21 lakh in FY25. The company’s board approved the standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026, in a meeting held on May 30, 2026. The company published extracts of these audited financial results in Free Press Indore (English) and Choutha Sansaar (Hindi) on June 1, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The statutory auditors, M/s Khandelwal Kakani & Company, issued an unmodified opinion on the annual audited standalone and consolidated financial results. The auditors confirmed that the results provide a true and fair view in conformity with the Indian Accounting Standards. The consolidated financial statements include the figures of subsidiary Puregene Biotech Limited.

For the quarter ended March 31, 2026, the company reported a consolidated net profit of ₹283.03 lakh, compared to a net loss of ₹320.92 lakh in the same period last year. Total revenue for the quarter stood at ₹24940.64 lakh, up from ₹23869.66 lakh in the corresponding quarter of the previous year. The profit before tax for the quarter was ₹453.93 lakh.

During the quarter ended March 31, 2026, the company allotted 1018300 equity shares with a face value of ₹10 each against the conversion of 1018300 convertible warrants on a preferential basis. The conversion was executed at an exercise price of ₹155 per share, inclusive of a securities premium of ₹145 per share. This increased the paid-up equity share capital to ₹481.00 lakh as of March 31, 2026.

Financial Performance

The table below summarizes the standalone and consolidated financial results for Simran Farms Limited for the quarter and year ended March 31, 2026.

Assets and Liabilities

As of March 31, 2026, the company’s total consolidated assets stood at ₹17730.86 lakh, a decrease from ₹18945.40 lakh in the previous year. Equity share capital increased to ₹481.00 lakh from ₹379.17 lakh, primarily due to the conversion of warrants. Total equity and liabilities amounted to ₹17730.86 lakh, matching the total assets. Non-current liabilities were recorded at ₹288.04 lakh, while current liabilities stood at ₹11621.96 lakh.

Simran Farms Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The meeting is scheduled to take place at the company's registered office located at 1-B, Vikas Rekha Complex, Khatiwala Tank, Indore (M.P.) 452001. The primary agenda for the meeting is to consider and approve the financial statements for the fiscal year ending March 31, 2026.

Agenda for the Meeting

The board will deliberate on the standalone as well as consolidated audited financial results of the company for the quarter and year ended on March 31, 2026. Along with the financial results, the board will also consider the audit report thereon. The meeting will also cover other routine matters with the permission of the chair.

Trading Window Closure

In accordance with the company's Code of Conduct to regulate, monitor, and report trading in company securities by insiders, the trading window remains closed. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the window will open for all designated persons, their immediate relatives, and connected persons 48 hours after the declaration of the standalone and consolidated audited financial results.

Meeting Details

The following table summarizes the key details of the upcoming board meeting:

The intimation for this meeting was filed with BSE Limited on May 21, 2026, under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.